TOP-1210

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameTOP-1210

Drug Alias NameTOP-1210

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSpleen tyrosine kinase inhibitorsP38 mitogen-activated protein kinase inhibitors

TargetsP38 mitogen-activated protein kinaseSpleen tyrosine kinase

Therapy Area/IndicationsColitis, Ulcerative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTopivert Pharma

China Registration ClassN/A

Active CompaniesTopivert Pharma

Inactive CompaniesN/A

Active IndicationsColitis, Ulcerative

Inactive IndicationsN/A

ATC CodeN/A